Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349633![]() (2-(4-Chlorophenyl)-2-(1-((3,5-dimethyl-1H-pyrazol-...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349645![]() (2-(4-Chlorophenyl)-2-(1-((1,3,5-trimethyl-1H-pyraz...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349636![]() (2-(4-Chlorophenyl)-2-(1-((3,5-diethyl-1H-pyrazol-4...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349653![]() (3-((1-(3,5-Dimethyl-1H-pyrazol-4-yl)sulfonyl)piper...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349639![]() (2-(1-((3,5-Dimethyl-1H-pyrazol-4-yl)sulfonyl)piper...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349646![]() (4-((4-Chlorophenyl)fluoromethylene)-1-((3,5-dimeth...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349635![]() (2-(4-Chloro-2-fluorophenyl)-2-(1-((3,5-dimethyl-1H...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349650![]() (4-((4-Chloro-3-fluorophenyl)fluoromethylene)-1-((3...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349637![]() (2-(4-Chlorophenyl)-2-(1-((1,5-dimethyl-3-(trifluor...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349648![]() (4-((2,4-Dichlorophenyl)fluoromethylene)-1-((3,5-di...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349651![]() (4-((4-Chloro-2-fluorophenyl)fluoromethylene)-1-((3...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349640![]() (2-(4-Chlorophenyl)-2-(1-((3,5-dimethyl-1H-pyrazol-...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 470 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349649![]() (4-((3,4-Dichlorophenyl)fluoromethylene)-1-((3,5-di...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 520 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349642![]() (4-(4-Chloro-2-fluorobenzylidene)-1-((1,3,5-trimeth...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349641![]() (4-(4-Chloro-2-fluorobenzylidene)-1-((3,5-dimethyl-...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349644![]() (4-(4-Chlorobenzylidene)-1-((3,5-dimethyl-1H-pyrazo...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 760 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349643![]() (4-(1-(4-Chlorophenypethylidene)-1-((3,5-dimethyl-1...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 760 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349631![]() (4-(4-Chloro-3-fluorobenzyl)-1-((3-cyclopropyl-5-me...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349652![]() (4-((2,4-Difluorophenyl)fluoromethylene)-1-(3,5-dim...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.63E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349647![]() (4-((3-Chloro-4-fluorophenyl)fluoromethylene)-1-((3...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.88E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349632![]() (Methyl 2-(4-Chlorophenyl)-2-(1-((3,5-dimethyl-1H-p...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349634![]() (2-(2,6-Difluorophenyl)-2-(1-((3,5-dimethyl-1H-pyra...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.68E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prokineticin Receptor 1 (PKR1) (Homo sapiens (Human)) | BDBM349638![]() (2-(2,6-Difluorophenyl)-2-(1-((1,3,5-trimethyl-1H-p...) | Reactome pathway KEGG GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.43E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description Prokineticin receptor 1 (PKR1) antagonists may be functionally assessed by measurement of change in intracellular calcium levels induced by Gq mediat... | US Patent US10208016 (2019) | |||||||||||
More data for this Ligand-Target Pair |